A novel non-Hodgkin lymphoma murine model closer to the standard clinical scenario

Background: Non-Hodgkin lymphomas (NHL) are the most frequent hemato-oncological malignancies. Despite recent major advances in treatment, a substantial proportion of patients relapses highlighting the need for new therapeutic modalities. Promissory results obtained in pre-clinical studies are usual...

Full description

Bibliographic Details

Main Author:	Bascuas, Thais (author)
Other Authors:	Moreno, María (author), Mónaco, Amy (author), Reyes, Laura (author), Paolino, Andrea (author), Oliver, Patricia (author), Kramer, María G. (author), Engler, Henry (author), Pacheco, José P. (author), Grille, Sofía (author), Chabalgoity, José A. (author)
Format:	article
Language:	English
Published:	2016
Subjects:	Non-Hodgkin lymphoma (NHL) Immunotherapy, Chemotherapy CHOP Clinical Positron emission tomography (PET) Minimal residual disease (MRD)
Online Access:	https://hdl.handle.net/20.500.12008/42096
Tags:	Add Tag No Tags, Be the first to tag this record!